Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracey M Gloster

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Nucleic Acids Research|July 12, 2025
SAM-AMP lyases in type III CRISPR defenceHaotian Chi, Stephen McMahon, Lukas Daniel-Pedersen, et al.
Journal of the American Chemical Society|February 7, 2007
Glycosidase inhibition: an assessment of the binding of 18 putative transition-state mimicsTracey M Gloster, Peter Meloncelli, Robert V Stick, et al.
Nature Communications|January 26, 2020
Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylateStephen A McMahon, Wenlong Zhu, Shirley Graham, et al.
Nature Chemical Biology|January 25, 2011
Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cellsTracey M Gloster, Wesley F Zandberg, Julia E Heinonen, et al.
Chemistry & Biology|September 21, 2010
Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytesMatthew S Macauley, Yuan He, Tracey M Gloster, et al.
Nucleic Acids Research|March 12, 2024
CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23Sabine Grüschow, Stuart McQuarrie, Katrin Ackermann, et al.
Nucleic Acids Research|February 16, 2021
The CRISPR ancillary effector Can2 is a dual-specificity nuclease potentiating type III CRISPR defenceWenlong Zhu, Stuart McQuarrie, Sabine Grüschow, et al.
Biochemistry|May 6, 2016
Mechanism of Human Nucleocytoplasmic Hexosaminidase DMatthew G Alteen, Verena Oehler, Ivana Nemčovičová, et al.
The Journal of Biological Chemistry|September 10, 2004
Structural, thermodynamic, and kinetic analyses of tetrahydrooxazine-derived inhibitors bound to beta-glucosidasesTracey M Gloster, James M Macdonald, Chris A Tarling, et al.
The Journal of Biological Chemistry|December 13, 2003
Structural and biochemical analysis of Cellvibrio japonicus xylanase 10C: how variation in substrate-binding cleft influences the catalytic profile of family GH-10 xylanasesGavin Pell, Lóránd Szabo, Simon J Charnock, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Nucleic Acids Research|July 12, 2025
SAM-AMP lyases in type III CRISPR defenceHaotian Chi, Stephen McMahon, Lukas Daniel-Pedersen, et al.
Journal of the American Chemical Society|February 7, 2007
Glycosidase inhibition: an assessment of the binding of 18 putative transition-state mimicsTracey M Gloster, Peter Meloncelli, Robert V Stick, et al.
Nature Communications|January 26, 2020
Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylateStephen A McMahon, Wenlong Zhu, Shirley Graham, et al.
Nature Chemical Biology|January 25, 2011
Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cellsTracey M Gloster, Wesley F Zandberg, Julia E Heinonen, et al.
Chemistry & Biology|September 21, 2010
Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytesMatthew S Macauley, Yuan He, Tracey M Gloster, et al.
Nucleic Acids Research|March 12, 2024
CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23Sabine Grüschow, Stuart McQuarrie, Katrin Ackermann, et al.
Nucleic Acids Research|February 16, 2021
The CRISPR ancillary effector Can2 is a dual-specificity nuclease potentiating type III CRISPR defenceWenlong Zhu, Stuart McQuarrie, Sabine Grüschow, et al.
Biochemistry|May 6, 2016
Mechanism of Human Nucleocytoplasmic Hexosaminidase DMatthew G Alteen, Verena Oehler, Ivana Nemčovičová, et al.
The Journal of Biological Chemistry|September 10, 2004
Structural, thermodynamic, and kinetic analyses of tetrahydrooxazine-derived inhibitors bound to beta-glucosidasesTracey M Gloster, James M Macdonald, Chris A Tarling, et al.
The Journal of Biological Chemistry|December 13, 2003
Structural and biochemical analysis of Cellvibrio japonicus xylanase 10C: how variation in substrate-binding cleft influences the catalytic profile of family GH-10 xylanasesGavin Pell, Lóránd Szabo, Simon J Charnock, et al.
Pageof 6